Form 4: Opaleye Management Boosts SANUWAVE Stake
Insider Transaction Report
Opaleye Management Inc., a 10% owner and director, purchased 1,267 shares of SANUWAVE Health common stock for approximately $30.28 per share.
Summary
- Opaleye Management Inc., acting as a 10% owner and director of SANUWAVE Health, Inc. (SNWV), acquired additional shares.
- On October 6, 2025, Opaleye Management Inc. purchased 1,267 shares of SANUWAVE Health, Inc. common stock.
- The shares were acquired at a weighted average price of $30.277 per share, with transaction prices ranging from $29.75 to $30.50.
- Following this transaction, Opaleye Management Inc. beneficially owns a total of 981,267 shares of SANUWAVE Health, Inc. common stock.
- This total includes 966,267 shares held indirectly by Opaleye, L.P., and 15,000 shares held indirectly by a separately managed account.
Sentiment
Score: 7
Explanation: The purchase by a significant insider and director is generally a positive signal, indicating confidence in the company's valuation and future prospects. While the transaction size is not massive, it reinforces existing ownership.
Positives
- A significant shareholder and director, Opaleye Management Inc., increased its stake in SANUWAVE Health, Inc., indicating continued confidence in the company's future prospects.
- The purchase of 1,267 shares at an average price of $30.277 suggests a belief that the current stock price offers value.
Management Comments
- Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Industry Context
This insider purchase by a significant shareholder and director suggests continued confidence in SANUWAVE Health's specific business trajectory rather than reflecting broader industry trends. Such transactions are typically company-specific.
Related Party Transactions
- Opaleye Management Inc. is a 10% owner and director of SANUWAVE Health, Inc., making this stock purchase a related party transaction under SEC rules.
Stakeholder Impact
- Shareholders may view this insider purchase as a positive signal, potentially increasing confidence in the company's stock.
- The transaction itself has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 10/06/2025 | Date of earliest transaction for common stock acquisition. |
| 10/09/2025 | Date the Form 4 was signed by James Silverman, President of Opaleye Management Inc. |
Recommendation
holdWhile the insider purchase by Opaleye Management Inc. is a positive indicator of confidence from a significant shareholder and director, the transaction size of 1,267 shares, though notable, is not substantial enough to warrant a 'buy' recommendation on its own. It reinforces a 'hold' position for existing investors, suggesting that the insider sees value at the current price, but does not present new fundamental information that would drastically alter the investment thesis for new capital.
Keywords
SANUWAVE Health, SNWV, Opaleye Management, Insider Trading, Stock Purchase, Beneficial Ownership, Form 4, Director Purchase, 10% Owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.